XTI Aerospace, Inc. (XTIA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated October 21, 2025, discloses a material definitive agreement entered into by XTI Aerospace, Inc. The filing details a strategic investment in Valkyrie Sciences Holdings LLC and related entities, alongside a concurrent consulting agreement.
Key Financial Metrics and Transaction Details
- Investment Amount: $2.0 million principal in a convertible promissory note.
- Interest Rate: 10% per annum (or maximum permissible by law), payable at maturity.
- Maturity Date: December 31, 2026.
- Consulting Fees: $600,000 plus approved expenses for a statement of work with Valkyrie Intelligence LLC (October 1, 2025 – January 23, 2026).
- Valuation Cap: $65 million applicable to conversion upon a "Sale" event.
- Right of First Offer (ROFO): Up to $10 million or 50% of new securities (whichever is less).
- Right of Participation: Up to $50 million in aggregate for future offerings.
Material Changes and Transaction Structure
The Company has entered into a convertible promissory note with Valkyrie Sciences Holdings LLC and its affiliate Valkyrie Andromeda Corporation. Key structural features include:
- Conversion Rights: The Note may convert into equity during a Qualified Financing at the price paid by new investors. Upon a Sale event, conversion is available at a price based on the lesser of the equity value, lowest valuation cap, or the $65 million cap.
- SAFE Conversion: The Company may convert 25% or more of the remaining balance into an Andromeda Simple Agreement for Future Equity (SAFE) prior to the SAFE closing or maturity.
- Default Provisions: Default triggers immediate repayment with interest increasing to 18% per annum.
- Most Favored Nations: The Note automatically adopts more favorable terms if the Borrower issues subsequent debt or SAFEs with better terms.
- Related Party Transaction: Charlie Burgoyne, CEO of Valkyrie/Andromeda/Intelligence, serves on XTI's corporate advisory board. The consulting agreement is with Valkyrie Intelligence LLC.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, revenue outlook, or liquidity metrics for XTI Aerospace itself. The primary risk disclosed relates to the concentration of the $2 million investment in a single private entity (Valkyrie) and the potential for the investment to be subordinate to future debt without consent. The Borrower is restricted from incurring additional debt or fundamentally changing its business without XTI's consent.
Investor Verification Checklist
- Verify the financial health and capitalization status of Valkyrie Sciences Holdings LLC and Valkyrie Andromeda Corporation.
- Confirm the status of the "Andromeda SAFE" offering and whether the $65 million valuation cap is competitive with current market terms.
- Review the full text of the Statement of Work with Valkyrie Intelligence LLC to assess the scope of services justifying the $600,000 fee.
- Monitor for any "Qualified Financing" or "Sale" events that would trigger conversion or repayment.
- Assess the impact of the $2 million outflow on XTI's current cash position and working capital.